Orthofix Medical (OFIX) Among the Best Small-Cap Growth Stocks To Buy Now

Orthofix Medical Inc. (NASDAQ:OFIX) is one of the Best Small-Cap Growth Stocks to Invest In Now. The stock has declined roughly 22% since its fiscal Q1 2026 earnings. Despite the softness, the Street remains bullish, with analysts’ 12-month price target suggesting more than 54% upside from the current level.

​Orthofix Medical Inc. (NASDAQ:OFIX) released earnings last month on May 5. During the quarter, the revenue came in at $196.71 million and surpassed the estimates of $194.71 million. ​Management noted that performance varied by segment. Spine Fixation grew 6%, supported by stronger commercial execution and procedural penetration; Therapeutic Solutions grew 5%, and Limb Reconstruction grew 10% on a reported basis.

​Orthofix Medical Inc. (NASDAQ:OFIX)  last issued guidance on May 21, 2026 for fiscal year 2026. It expects net sales for full-year 2026 to be in the range of $838 million to $848 million and non-GAAP adjusted EBITDA to be in the range of $90 million to $93 million. At this time, the Company does not expect positive free cash flow for full-year 2026.

Orthofix Medical Inc. (NASDAQ:OFIX) is a global medical device company focused on spine and orthopedic solutions. It develops and markets implants, biologics, and bone growth therapies to support musculoskeletal healing and improve patient mobility and recovery outcomes.

While we acknowledge the risk and potential of OABI as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than OABI and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: Top 10 Large-Cap Stocks to Invest In At 52-Week Lows and 12 High Growth Semiconductor Stocks to Buy Now. 

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1